TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/25/24 18:24 | 1/23/24 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Lurker Nancy | MA | DO | Exec Vic | S.dm | -874 | 24.98 | 0 | -35 | -16 | 188 | D | ||||||||||||||
12/6/23 17:18 | 12/4/23 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Lurker Nancy | MA | DO | Exec Vic | S | -415 | 20.76 | 0 | -20 | -10 | 171 | D | ||||||||||||||
11/17/21 17:03 | 11/15/21 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Lurker Nancy | MA | DO | P,CEO | S | -201 | 20.15 | 0 | -10 | -9 | 104 | D | ||||||||||||||
12/8/14 16:18 | 12/5/14 | AUXL | Auxilium Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lurker Nancy | PA | D | S.d | -1,103 | 34.00 | 0 | -32 | -76 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |